Organon (OGN) R&D In Process (2021 - 2025)
Historic R&D In Process for Organon (OGN) over the last 5 years, with Q1 2025 value amounting to $6.0 million.
- Organon's R&D In Process fell 6000.0% to $6.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 9259.26%. This contributed to the annual value of $81.0 million for FY2024, which is 91250.0% up from last year.
- Per Organon's latest filing, its R&D In Process stood at $6.0 million for Q1 2025, which was down 6000.0% from $51.0 million recorded in Q3 2024.
- In the past 5 years, Organon's R&D In Process registered a high of $97.0 million during Q2 2022, and its lowest value of $6.0 million during Q1 2025.
- Over the past 5 years, Organon's median R&D In Process value was $15.0 million (recorded in 2024), while the average stood at $34.0 million.
- Its R&D In Process has fluctuated over the past 5 years, first tumbled by 6000.0% in 2022, then surged by 8750.0% in 2024.
- Over the past 5 years, Organon's R&D In Process (Quarter) stood at $79.0 million in 2021, then crashed by 87.34% to $10.0 million in 2022, then fell by 20.0% to $8.0 million in 2023, then skyrocketed by 537.5% to $51.0 million in 2024, then crashed by 88.24% to $6.0 million in 2025.
- Its R&D In Process stands at $6.0 million for Q1 2025, versus $51.0 million for Q3 2024 and $15.0 million for Q2 2024.